.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Chubb
Merck
Johnson and Johnson
Boehringer Ingelheim
Express Scripts
Covington
Accenture
Moodys
Argus Health

Generated: November 19, 2017

DrugPatentWatch Database Preview

Impax Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for IMPAX PHARMS, and what generic and branded alternatives to IMPAX PHARMS drugs are available?

IMPAX PHARMS has seven approved drugs.

There is one tentative approval on IMPAX PHARMS drugs.

Summary for Impax Pharms

US Patents:0
Tradenames:7
Ingredients:7
NDAs:7
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Pharms
SOTALOL HYDROCHLORIDE
sotalol hydrochloride
TABLET;ORAL075663-004Nov 7, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL076745-003May 9, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
FLAVOXATE HYDROCHLORIDE
flavoxate hydrochloride
TABLET;ORAL076234-001Aug 28, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
MIDODRINE HYDROCHLORIDE
midodrine hydrochloride
TABLET;ORAL076449-001May 27, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
SOTALOL HYDROCHLORIDE
sotalol hydrochloride
TABLET;ORAL075663-002Nov 7, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
SOTALOL HYDROCHLORIDE
sotalol hydrochloride
TABLET;ORAL075663-001Nov 7, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
MIDODRINE HYDROCHLORIDE
midodrine hydrochloride
TABLET;ORAL076449-002May 27, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
MIDODRINE HYDROCHLORIDE
midodrine hydrochloride
TABLET;ORAL076449-003Dec 16, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
ORPHENADRINE CITRATE
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL040368-001Jun 23, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL076745-002May 9, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Harvard Business School
Julphar
Fish and Richardson
Dow
Queensland Health
McKinsey
UBS
Moodys
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot